EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.

Authors :: Gaucher S
Lwin SM
Titeux M
Abdul-Wahab A
Pironon N
Izmiryan A
Miskinyte S
Ganier C
Duchatelet S
Mellerio JE
Bourrat E
McGrath JA
Hovnanian A
Source :: The British journal of dermatology [Br J Dermatol] 2020 Mar; Vol. 182 (3), pp. 794-797. Date of Electronic Publication: 2019 Nov 27.
Publication Year :: 2020

Subjects :: Collagen Type VII genetics
Genes, Recessive
Genetic Therapy
Humans
Epidermolysis Bullosa genetics
Epidermolysis Bullosa Dystrophica genetics
Epidermolysis Bullosa Dystrophica therapy

Full Text Access

Tools